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Abstract. Previous studies have demonstrated that excessive reactive oxygen/nitrogen species (ROS/RNS)‑induced
apoptosis is an important feature of the injury to the lung
epithelium in paraquat (PQ) poisoning. However the precise
mechanisms of PQ‑induced dysfunction of the mitochondria,
where ROS/RNS are predominantly produced, remain to be
fully elucidated. Whether globular adiponectin (gAd), a potent
molecule protective to mitochondria, regulates the mitochondrial function of alveolar type II cells to reduce PQ‑induced
ROS/RNS production remains to be investigated. The current
study aimed to investigate the precise mechanisms of PQ
poisoning in the mitochondria of alveolar type II cells, and
to elucidate the role of gAd in protecting against PQ‑induced
lung epithelium injury. Therefore, lung epithelial injury was
induced by PQ co‑culture of alveolar type II A549 cells for
24 h. gAd was administrated to and removed from the injured
cells in after 24 h. PQ was observed to reduce cell viability
and increase apoptosis by ~1.5 fold in A549 cells. The oxidative/nitrative stress, resulting from ROS/RNS and disordered
mitochondrial function were evidenced by increased O2‑.,
NO production and reduced mitochondrial membrane
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potential (ΔΨ ), adenosine 5'‑triphosphate (ATP) content in
PQ‑poisoned A549 cells. gAd treatment significantly reversed
the PQ‑induced cell injury and mitochondrial dysfunction in
A549 cells. The protective effects of gAd were partly abrogated by an adenosine 5'‑monophosphate‑activated protein
kinase (AMPK) inhibitor, compound C. The results suggest
that reduced ΔΨ and ATP content may result in PQ‑induced
mitochondrial dysfunction of the lung epithelium, which
constitutes a novel mechanism for gAd exerting pulmonary
protection against PQ poisoning via AMPK activation.
Introduction
Previous studies have demonstrated that apoptosis is an
important process in injured to the lung epithelium in paraquat (PQ) poisoning (1,2). The mechanisms of apoptosis are
highly complex and involve oxidative/nitrative stress impairment to the function of mitochondria with the reduction of
the mitochondrial membrane potential (ΔΨ), resulting in an
increase of superoxide formation and reduced production
of adenosine 5'‑triphosphate (ATP) (3,4). Previous studies
suggest that adenosine 5'‑monophosphate‑activated protein
kinase (AMPK) is one of the most important molecules in the
stimulation of ATP production and protection against oxidative/nitrative stress in mitochondria (5,6). However, whether
dysfunction of the mitochondria and reduction of ATP via
inactivation of AMPK serve crucial roles in the PQ‑induced
apoptosis of alveolar epithelial type II cells remains to be fully
elucidated.
Adiponectin (APN), an adipocytokine predominantly
secreted by adipocytes and found at high levels in the
plasma, has been reported to exhibit anti‑insulin resistance
and anti‑inflammatory and anti‑apoptotic properties (7‑9).
Circulating APN is present as trimeric, hexameric or oligomeric complexes of monomers, and cleavage to produce the
C‑terminal globular domain, gAd, has been proposed as an
important regulatory step in the action of APN. This is due
to the fact that this C‑terminal fragment has been reported to
mediate potent physiological effects (10,11). Previous studies
have suggested that the potential role of gAd against apoptosis
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is mediated via the activation of AMPK (12‑14). APN‑knockout
mice exhibit inhibition of AMPK, a reduction in the levels of
ATP, an increase of mitochondrial swelling and ROS/RNS
production, resulting in augmented apoptosis, while administration of gAd reversed these effects. The protective effects
of gAd have been reported to be reversed by administration
of the AMPK inhibitor (compound C) (15). It remains unclear
whether APN may protect alveolar type II cells from PQ
poisoning via activation of AMPK and increasing the production of ATP in mitochondria.
Therefore, the aims of the current study were: i) To determine whether mitochondrial function is impaired and ATP
is reduced in PQ‑poisoned alveolar type II cells via inactivation of AMPK; ii) to determine the effect of gAd against
PQ‑induced apoptosis and in alveolar type II cells; and if so,
iii) whether gAd mediates protective effects via activation of
AMPK and increasing production of ATP.
Materials and methods
Materials. All reagents were purchased from Sigma‑Aldrich
(St. Louis, MO, USA), unless otherwise specified. RPMI 1640
medium was obtained from Gibco; Thermo Fisher Scientific,
Inc. (Waltham, MA, USA). Penicillin/streptomycin was
obtained from Wisent, Inc. (Saint-Bruno, QC, Canada).
PQ was purchased from Tokyo Chemical Industry Co.,
Ltd. (Tokyo, Japan). The globular domain of APN (gAd)
was purchased from Beijing Adipobiotech, Inc. (Beijing,
China). Compound C, an AMPK Inhibitor, was obtained
from Merck Millipore (Darmstadt, Germany). The
Annexin V‑Fluorescein Isothiocyanate (FITC) Apoptosis
Detection kit I was from Nanjing KeyGen Biotech Co., Ltd.
(Nanjing, China). JC‑1 and dihydroethidium (DHE) were
purchased from Molecular Probes; Thermo Fisher Scientific,
Inc. The Nitrate/Nitrite Colorimetric Assay kit was from
Nanjing Jiancheng Biochemical Reagent Co. (Nanjing, China).
The ATP Bioluminescent Somatic Cell assay kit was from
Sigma‑Aldrich.
Cell cultures and treatments. The human lung adenocarcinoma
cell line A549 (Shanghai Institute of Biochemistry and Cell
Biology, Shanghai, China) was grown in a monolayer culture
in RPMI 1640 medium supplemented with 10% fetal bovine
serum, 1% glutamine, 1% (v/v) streptomycin/penicillin. The
culture medium was refreshed two to three times per week
and was subcultured upon reaching 80% confluence. The cells
were then seeded onto flat‑bottom six‑well or 96‑well plates
with growth medium at 37˚C in a humidified atmosphere at 5%
CO2, followed by administration of PQ at 300 µM for 24 h for
the PQ, PA and PCA groups. Subsequently, gAd (2.5 µg/ml)
was added and the cells were cultured for another 24 h, in
order to investigate the role of gAd in PQ‑induced cytotoxicity.
PCA group cells were also treated with compound C (1 µM)
for 30 min prior to the addition of PQ. The optimal doses and
time points for gAd, PQ and compound C were determined
through preliminary experiments (data not shown).
Measurement of cell viability. The 3‑(4, 5‑methylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide (MTT) assay was
conducted as previously described (16). Briefly, following PQ
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challenge, culture media was refreshed with media containing
MTT reagent (5 mg/ml) and cells were incubated under standard conditions for an additional 4 h. The culture media was
then carefully aspirated and 100 µl dimethylsulfoxide was
added per well to solubilize the formazan crystals. Following
agitation, absorbance was measured spectrophotometrically at
a wavelength of 490 nm using a Benchmark Plus Microplate
Spectrophotometer (Bio‑Rad Laboratories, Inc., Hercules, CA,
USA). Viabilities of the challenged cells were expressed relative to control cells.
Measurement of necrosis and apoptosis. Apoptotic and
necrotic cell death were measured using flow cytometry with
the Annexin V‑FITC Apoptosis Detection kit I (17). At 24 h
after administration of gAd, cells were trypsinized (Thermo
Fisher Scientific, Inc.) without ethylenediaminetetraacetic acid
and labelled with the fluorochromes in the absence of light for
10 min at room temperature. Fluorescence was measured by
flow cytometric analysis using a FACSCalibur flow cytometer
(BD Biosciences, San Jose, CA, USA) to monitor green fluorescence (525 nm band‑pass filter) for Annexin V‑fluorescein
conjugate and red fluorescence (575 nm band‑pass filter) for
PI respectively. The Annexin V‑FITC‑/PI‑cell population was
regarded as normal, while Annexin V‑FITC+/PI‑cells were
taken as an indicator of early apoptosis, Annexin V‑FITC+/PI+
as late apoptosis and Annexin V‑FITC‑/PI+ as necrosis. The
data were analyzed using CellQuest software (BD Biosciences).
A minimum of 30,000 gated events were acquired per sample.
Measurement of superoxide production. Production
of superoxides was evaluated intracellularly using the
superoxide‑sensitive dye DHE (18). DHE is oxidized by superoxides to a novel product, which binds to DNA enhancing
intracellular fluorescence. Culture medium was aspirated
and cells were incubated with DHE (5 µM final concentration) for 10 min at 37˚C in the dark. Following two rinses
in phosphate‑buffered saline, cells were photographed using
an Axiostart 50 (Zeiss, Oberkochen, Germany) microscope
equipped with a Canon PowerShot G5 epifluorescence
attachment (Canon, Inc., Tokyo, Japan). Between five and six
photographs were captured from each well. The fluorescence
intensity values for each photo were determined using Adobe
Photoshop software (version 4; Adobe Systems, Inc., San Jose,
CA, USA).
Measurement of nitrites. Nitrites were measured in the culture
supernatants by a colorimetric assay using a procedure based
on the Greiss reaction with sodium nitrite as the standard (19).
Culture medium was collected and stored at ‑80˚C until analysis with the Nitrate/Nitrite Colorimetric Assay kit, according
to the manufacturer's instructions.
Measurement of ΔΨ. The membrane potential assay was
conducted as previously described (20). The relative ΔΨ was
assessed using a laser scanning confocal microscope (SP8;
Leica Microsystems GmbH, Wetzlar, Germany) analysis of
cells stained with JC‑1. Cells were incubated with 10 µg/ml
JC‑1 for 30 min at 37˚C. Subsequent to applying the dye, the
cells were scanned with the confocal microscope using a
10x objective lens. Fluorescence was excited by the 488‑nm
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Figure 1. Cellular‑protective effect of gAd on PQ‑induced A549 cells. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without adenosine
5'‑monophosphate‑activated protein kinase inhibitor (compound C) pretreatment. The 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay
was performed at 24 h subsequent to the administration of gAd. The data are presented as the mean ± standard deviation of five independent experiments,
*
P<0.05. gAd, globular adiponectin; PQ, paraquat.

line of an argon laser and the 543‑nm line of a helium/neon
laser. The red emission of the dye is due to a potential‑dependent aggregation in the mitochondria, reflecting high ΔΨ.
Green fluorescence indicates the monomeric form of JC‑1,
appearing in the cytosol following mitochondrial membrane
depolarization, indicating low ΔΨ. The ratio of red/green
indicated the mitochondrial membrane depolarization states
of different cells.
Measurement of ATP. The amount of ATP was measured
in the cultured cells using a luminometer (Bio Orbit 1251
Luminometer; Bio‑Orbit, Turku, Finland) as previously
described (21). Subsequent to exposure to different experimental conditions, cells were collected to react with different
working solutions of from the ATP Bioluminescent Somatic
Cell assay kit, according to the manufacturer's instructions.
All reactions for a given sample were monitored simultaneously and calibrated with the addition of an ATP standard
from the kit.

cytotoxicity, reducing the percentage of apoptotic cells to
22.3% (P<0.01). However, the pretreatment with compound C
significantly reversed gAd's protective effect (Fig. 2).
gAd reduced PQ‑mediated superoxide production. As
presented in Fig. 3, control cultures generally exhibited low
fluorescence intensity while PQ‑treated cultures exhibited
bright red fluorescence. This indicated that PQ significanlty
increased O2‑. production in cells compared with that of the
controls (P<0.001). gAd inhibited the O2‑. production induced
by PQ significanlty. However, pre‑treatment with compound C
partly reversed gAd's effects on O2‑. production.
gAd reduced PQ‑mediated nitrite production. Addition of
PQ to the cultures significantly increased nitrite production
compared with the controls (P<0.01). Administration of gAd
or compound C significantly reversed the increase, however
pre‑treatment with compound C did not reverse the effects of
gAd on nitrite production (Fig. 4).

Statistics. Data are presented as the mean ± standard error (n=5)
and were analyzed for statistical significance by one‑ or two‑way
analysis of variance with were least significant difference or
Student-Newman-Keuls post hoc analyses. Statistical analysis
and the significance of the data were determined using SPSS
software, version 12.0 (SPSS, Inc., Chicago, IL, USA). P<0.05
was considered to indicate a statistically significant difference.

gAd reduced PQ‑mediated ΔΨ depolarization. Incubation
with PQ depolarized the ΔΨ significantly, resulting in a low
ratio of red/green. Treatment with gAd repolarized the ΔΨ of
the cells, resulting in a greater ratio of red/green, compared
with PQ group (P<0.01). However, compound C reversed the
repolarization of gAd, resulting in a lower ratio of red/green as
compared with the gAd group (P<0.01; Fig. 5).

Results

gAd partly reversed the PQ‑mediated reduction in ATP.
Addition of PQ significantly reduced the intracellular ATP
concentration, as compared with the initial control levels: 21%
after 24 h, irrespective of the presence of other medium supplements or stimulation (P<0.05). Conversely, treatment with gAd
increased the ATP level to ~50% of that of the control group
(P<0.05). However, compound C reversed the gAd‑mediated
increase (P<0.05; Fig. 6).

gAd reduced PQ‑mediated cytotoxicity. As presented in Fig. 1,
PQ significantly reduced the cell viability of A549 cells, while
gAd alleviated the PQ‑induced cytotoxicity without any effects
on the cells alone. However, pretreatment with compound C
significantly reversed the protective effects of gAd on the
viability reduced by PQ.
gAd reduced PQ‑mediated apoptosis. The results indicated that
there was a low level of cell death in the control group (Fig. 2A).
However, PQ was observed to induce apoptosis in ~37.5% cells
(Fig. 2B). However, gAd significantly reversed the PQ‑induced

Discussion
The most prevalent cause of morbidity and mortality in patients
with PQ poisoning is organ injury, in particular, injury to the
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Figure 2. Anti‑apoptotic effects of gAd on PQ‑induced A549 cells. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without adenosine
5'‑monophosphate‑activated protein kinase inhibitor (compound C) pretreatment. The flow cytometry assay was conducted 24 h subsequent to administration
of gAd. Flow cytometry analysis of the (A) control, (B) PQ, (C) PA and (D) PCA groups are presented. (E) Percentage of apoptosis and necrosis for the four
groups are presented as the mean ± standard deviation of five independent experiments, *P<0.05. gAd, globular adiponectin; PQ, paraquat; PI, propidium
iodide; FITC, fluorescein isothiocyanate.
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Figure 3. Anti‑oxidative stress effects of gAd on PQ‑induced A549 cells. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without
adenosine 5'‑monophosphate‑activated protein kinase inhibitor (compound C) pretreatment. The fluorescence intensity of dihydroethidium was performed at
24 h after the administration of gAd. (A) Control group; (B) PQ group; (C) PA group; (D) PCA group; (E) Quantification of fluorescence data. The data are
presented as the mean ± standard deviation of five independent experiments, *P<0.05. gAd, globular adiponectin; PQ, paraquat.
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Figure 4. Anti‑nitrative stress effects of gAd on PQ‑induced A549 cells. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without
adenosine 5'‑monophosphate‑activated protein kinase inhibitor (compound C). A colorimetric assay was performed 24 h subsequent to the administration of
gAd. The data are presented as the mean ± standard deviation of five independent experiments, *P<0.05. gAd, globular adiponectin; PQ, paraquat.
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Figure 5. Effect of gAd on PQ‑mediated ΔΨ depolarization. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without adenosine
5'‑monophosphate‑activated protein kinase inhibitor (compound C). Confocal microscopy analysis was performed 24 h subsequent to the administration
of gAd on the (A) control, (B) PQ group, (C) PA group and (D) PCA group. The red emission of the dye is due to a potential‑dependent aggregation in the
mitochondria, indicating high ΔΨ. Green fluorescence indicates the monomeric form of JC‑1, appearing in the cytosol subsequent to mitochondrial membrane
depolarization, indicating low ΔΨ. The ratio of red/green indicated the mitochondrial membrane depolarization states of different cells. (E) Quantification of
the red/green ratio of the four groups is presented as the mean ± standard deviation of five independent experiments, *P<0.05. gAd, globular adiponectin; PQ,
paraquat; ΔΨ, mitochondrial membrane potential.

Figure 6. Effect of gAd on PQ‑mediated reduction in ATP. Cells were treated with 300 µM PQ followed by 2.5 µg/ml gAd with or without adenosine 5'‑monophosphate‑activated protein kinase inhibitor (compound C). The luminometer assay was performed 24 h subsequent to gAd administration. The data are
presented as the mean ± standard deviation of five independent experiments, *P<0.05. gAd, globular adiponectin; PQ, paraquat; ATP, adenosine 5'‑triphosphate.
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lungs (22). It has been demonstrated that excessive ROS/RNS
stress resulting from impaired mitochondria, is an important
feature of the injured lung epithelium in PQ poisoning, though
the underlying mechanism responsible for the mitochondrial dysfunction remains unclear (23). Therefore, studies
have focussed upon clarifying the underlying mechanisms
for PQ‑associated mitochondria injury of alveolar type II
cells (24,25) and developing novel strategies for the treatment
of PQ‑poisoned patients (26). In the present study, an established PQ poisoning model with A549 cells cultured with PQ
for 24 h was used, and it was confirmed that apoptosis and cell
death were exacerbated in the presence of PQ. Furthermore,
it was indicated that PQ markedly disturbed mitochondrial
function, depolarizing ΔΨ and reducing ATP production,
resulting in progressive increases of O2‑. and NO. This may
be explained by the fact that PQ2+ induced the release of Ca2+
from cytoplasm (27), which may induce the depolarization of
mitochondria and reduce ΔΨ (28). This results in reductions
of ATP synthesis to less than 50% of the normal level, thus
activating pro‑apoptotic and pro‑necrotic proteins, including
Bax and caspase 3/7/8/9 (29,30). As a result, the injured mitochondria produce excessive O2‑. and NO, which attached to the
mitochondrial membrane in turn, and resulted in increases in
ROS/RNS production and ultimately inducing apoptosis (31).
Injury resulting from PQ poisoning was however, reversed
by treatment with gAd in the current study. Although the associated mechanisms remain to be fully elucidated, a previous
study demonstrated the potential cellular protective effects of
gAd against apoptosis via inhibiting mitochondrial dysfunction and ROS/RNS attachment (32). Therefore, the current
study suggested that gAd may protect the alveolar type II cells
aginst PQ‑induced cell injury via inhibiting mitochondrial
dysfunction and reducing oxidative/nitrative injury.
In order to further elucidate the underlying mechanisms
for the cellular‑protective effects of gAd in PQ poisoning
against mitochondrial dysfunction and oxidative/nitrative
injury, the signaling of AMPK, a protective kinase in oxidative/nitrative injury and a downstream mediator of gAd's
mitochondrial protective actions, was investigated (33). It was
identified that the protective effects of gAd could be reversed
by an AMPK inhibitor, compound C, which has been previously identified to block the cardiac protective benefits of gAd
treatment against cardiac myocardial hypoxia/reoxygenation
injury (15). This result clarified the critical role of AMPK in
the pneumonocyte‑protective effects of gAd, indicating it may
be used in the therapy for PQ poisoning. This observation
is consistent with a previous study by Yan et al (15), which
demonstrated that gAd was able to activate AMPK‑peroxisome
proliferator‑activated receptor γ coactivator 1‑α, resulting in
increased ATP production, improving ΔΨ, thus leading to
return to normal function. These results indicate that AMPK
may be one of the key molecules in gAd's inhibition of mitochondrial dysfunction induced by PQ. However, interspecies
differences (34,35), animal model establishment (36,37) and
the injury procedure (38) may affect whether AMPK signaling
serves a beneficial or detrimental role in the mitochondria.
Experiments using animal models should be conducted in
order to further clarify the mechanisms.
There were limitations in the present study. The inactivation
of AMPK was not introduced when PQ was added to the cells,
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due to the high rate of mortality, thus the ability to directly
demonstrate the role of AMPK in PQ‑poisoned mitochondria
following oxidative/nitrative injury was compromised. In addition, gAd treatment in PQ poisoning may modulate numerous
other key molecules in addition to AMPK‑ATP (39‑41). Thus,
investigation of these molecules in oxidative/nitrative injury
requires additional investigation.
In conclusion, it was demonstrated that the ΔΨ exhibited
progressive reductions with increased oxidative/nitrative injury
in PQ‑induced apoptosis. In addition, it was identified that in
PQ poisoning, ΔΨ is increased in response to gAd treatment,
which significantly attenuated mitochondrial dysfunction and
oxidative/nitrative injury in PQ‑poisoned alveolar type II cells.
The present study provided indirect evidence for the possible
role of the AMPK‑ATP signaling pathway in gAd against
oxidative/nitrative injury originating from the mitochondria
following PQ poisoning. To the best of our knowledge, this is
the first study to demonstrate the ability of gAd in attenuating
oxidative/nitrative injury in PQ poisoning of lung cells beyond
its metabolic actions. These observations add to the current
understanding of the pathophysiology of PQ poisoning and
the mechanisms of the widely used gAd therapy. This may aid
in the development of future therapeutic strategies capable of
assisting gAd in protecting against PQ‑induced lung injury.
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